Relationship Between Final Height and Health Outcomes in Adults With Congenital Adrenal Hyperplasia: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE)
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
CONTEXT: Treatment of congenital adrenal hyperplasia (CAH) in childhood focuses on growth and development and adult final height (FH) is a measure of effective treatment. We hypothesized that shorter adults will have more severe underlying disease and worse health outcomes. METHODS: This was a cross-sectional analysis of 199 adults with CAH. FH and quality of life were expressed as z-scores adjusted for midparental target height or UK population height. RESULTS: FH correlated inversely with age (men, r = -0.38; women, r = -0.26, P < .01). Men and women had z-scores adjusted for midparental target height of -2 and -1, respectively, and both groups had UK population height z-scores of -1 below the UK population (P < .01). In women, FH was shorter in non-salt-wasting than salt-wasting classic CAH (P < .05) and in moderately affected genotype group B women than either more severely affected groups null and A (P < .01) or the mildest group C (P < .001). Short stature and a higher prevalence of hypertension were observed in classic CAH patients diagnosed late (after 1 y) compared with those diagnosed early and in women treated with glucocorticoid only compared with those treated with both glucocorticoids and mineralocorticoids (P < .05). FH did not associate with insulin sensitivity, lipid profile, adiposity, or quality of life. CONCLUSIONS: Adult CAH patients remain short, although height prognosis has improved over time. The shortest adults are those diagnosed late with moderate severity CAH and are at increased risk of adult hypertension; we hypothesize that these patients are exposed in childhood to high androgens and/or excessive glucocorticoids with potential programming of hypertension. Another possibility is inadequate mineralocorticoid treatment early in life in the late-diagnosed patient group. Prospective studies are now required to examine these hypotheses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, achieving the optimal dose and timings of hydrocortisone replacement to avoid the adverse effects of excessive glucocorticoid on growth and metabolism while maintaining adequate androgen suppression is challenging, resulting in poor health outcomes (28).”
From ACTH Antagonists (2016) · cites this paper as [28]
In the citing paper
“Patients have an increased morbidity and mortality in adult life that may in part relate to suboptimal glucocorticoid therapy in their early years of life ( Finkielstain et al., 2012 ; Han et al., 2014 ; Bancos et al., 2015 ; Bornstein et al., 2016 ).”
From Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach (2023) · cites this paper as Han et al., 2014
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Gender differences in the regulation of blood pressure
Reckelhoff, J. F. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1199 · Cited by 1,268
Glucocorticoid exposure in utero: new model for adult hypertension
Benediktsson, R., Lindsay, R. S., Noble, J., Seckl, J. R., & Edwards, C. R. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90138-7 · Cited by 863
Sesso, H. D., Stampfer, M. J., Rosner, B., Hennekens, C. H., Gaziano, J. M., Manson, J. E., & Glynn, R. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.801 · Cited by 599
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citation
Cited by
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
“, 2014 (30) United Kingdom Cross-sectional Adults 199 NA”
InfluentialImpact of short stature on quality of life: A systematic literature review
Backeljauw, P. F., Cappa, M., Kieß, W., Law, L., Cookson, C., Sert, C., Whalen, J. D., & Dattani, M. (2021) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2021.101392 · Cited by 115
“Generic HRQoL was significantly poorer in adults with skeletal dysplasia [41], childhood-onset multiple pituitary hormone deficiency [44] and congenital adrenal hyperplasia (CAH) [42] than in healthy control groups.”
BackgroundMethodInfluentialHan, T. S., Krone, N., Willis, D. S., Conway, G. S., Hahner, S., Rees, D. A., Stimson, R. H., Walker, B. R., Arlt, W., Ross, R. J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0128 · Cited by 79
Self-citationKing, T. F. J., Lee, M. C., Williamson, E. E. J., & Conway, G. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13001 · Cited by 66
Self-citationTorky, A., Sinaii, N., Jha, S., Desai, J., El‐Maouche, D., Mallappa, A., & Merke, D. P. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab133 · Cited by 84
“In a cross-sectional study of 199 adults with CAH in the United Kingdom, short stature was associated with hypertension (31); however, we did not find a relationship between adult height and hypertension or metabolic syndrome in our cohort.”
BackgroundNeumann, U., Whitaker, M. J., Wiegand, S., Krude, H., Porter, J., Davies, M., Digweed, D., Voet, B., Ross, R. J., & Blankenstein, O. (2018) · Clinical Endocrinology · doi:10.1111/cen.13447 · Cited by 64
Self-citationQuality of compounded hydrocortisone capsules used in the treatment of children
Neumann, U., Burau, D., Spielmann, S., Whitaker, M. J., Ross, R. J., Kloft, C., & Blankenstein, O. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0248 · Cited by 56
Self-citationIs physiological glucocorticoid replacement important in children?
Porter, J., Blair, J., & Ross, R. J. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-309538 · Cited by 50
Self-citationGrowth and development in children with classic congenital adrenal hyperplasia
Bonfig, W. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000308 · Cited by 52
Whitaker, M. J., Spielmann, S., Digweed, D., Huatan, H., Eckland, D., Johnson, T. N., Tucker, G., Krude, H., Blankenstein, O., & Ross, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4060 · Cited by 48
Self-citationClark, A. J., Forfar, R., Hussain, M., Jerman, J., McIver, E., Taylor, D., & Chan, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00101 · Cited by 49
“However, achieving the optimal dose and timings of hydrocortisone replacement to avoid the adverse effects of excessive glucocorticoid on growth and metabolism while maintaining adequate androgen suppression is challenging, resulting in poor health outcomes (28).”
BackgroundQuality of life in patients with adrenal disease: A systematic review
Ho, W., & Druce, M. (2018) · Clinical Endocrinology · doi:10.1111/cen.13719 · Cited by 44
Watson, C., Webb, E. A., Kerr, S., Davies, J. H., Stirling, H., & Batchelor, H. K. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.054 · Cited by 41
“There are long term consequences of poor hydrocortisone therapy in childhood as adult CAH patients who remain short may have been underexposed as children (Han et al., 2014).”
BackgroundBachelot, A., Vialon, M., Baptiste, A., Tejedor, I., Elie, C., Polak, M., Touraine, P., & _, _. (2017) · Endocrine Connections · doi:10.1530/ec-17-0094 · Cited by 34
Kim, J. H., Choi, S., Lee, Y. A., Lee, J., & Kim, S. G. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1328 · Cited by 33
“Previous studies on adverse outcomes in CAH patients were conducted in Western countries [6-11].”
ResultGrowth curves for congenital adrenal hyperplasia from a national retrospective cohort
Bretones, P., Riche, B., Pichot, E., David, M., Roy, P., Tardy, V., Kassaï, B., Gaillard, S., Bernoux, D., Morel, Y., et al. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0156 · Cited by 31
Abnormal linear growth in paediatric adrenal diseases: Pathogenesis, prevalence and management
Minnetti, M., Caiulo, S., Ferrigno, R., Ferroli, B. B., Bottaro, G., Gianfrilli, D., Sbardella, E., Martino, M. C. D., & Savage, M. O. (2019) · Clinical Endocrinology · doi:10.1111/cen.14131 · Cited by 38
Pijnenburg-Kleizen, K. J., Thomas, C. M. G., Otten, B. J., Roeleveld, N., & der Grinten, H. L. C. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0006 · Cited by 35
Porter, J., Withe, M., & Ross, R. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1455496 · Cited by 26
Long‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“186 Those with nonclassic CAH can also face growth implications, though usually less pronounced than in classic CAH.”
Vijayan, R., Bhavani, N., Pavithran, P. V., Nair, V., Menon, U. V., Menon, A. S., Abraham, N., Bhadran, K., Narayanan, P., & Kumar, H. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0079 · Cited by 22
Pediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Bacila, I. A., Lawrence, N., Mahdi, S., Alvi, S., Cheetham, T. D., Crowne, E. C., Das, U., Dattani, M., Davies, J. H., Gevers, E. F., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1109 · Cited by 24
Metwalley, K. A., Farghaly, H. S., & Abdelhamid, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492900 · Cited by 16
Righi, B., Ali, S., Bryce, J., Tomlinson, J., Bonfig, W., Baronio, F., Costa, E. C., Guaragna‐Filho, G., T'Sjoen, G. G., Cools, M., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03330-w · Cited by 15
Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
Itonaga, T., & Hasegawa, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1102741 · Cited by 11
Lim, S. G., Lee, Y. A., Jang, H. N., Kong, S. H., Ahn, C. H., Kim, S. W., Shin, C. H., & Kim, J. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761258 · Cited by 13
Johannsen, T. H., Albrethsen, J., Neocleous, V., Baronio, F., Cools, M., Aksglaede, L., Jørgensen, N., Christiansen, P., Toumba, M., Fanis, P., et al. (2023) · Endocrine Connections · doi:10.1530/ec-23-0073 · Cited by 9
Cohort profile: pathways to care among people with disorders of sex development (DSD)
Goodman, M. G., Yacoub, R., Getahun, D., McCracken, C., Vupputuri, S. X., Lash, T. L., Roblin, D. W., Contreras, R., Cromwell, L., Gardner, M. D., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063409 · Cited by 9
Liedmeier, A., Jendryczko, D., Rapp, M., Roehle, R., Thyen, U., & Kreukels, B. P. C. (2021) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2021.100087 · Cited by 12
Blood Pressure in Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Balagamage, C., Lawrence, N., Krone, R. E., Bacila, I. A., & Krone, N. P. (2023) · Hormone Research in Paediatrics · doi:10.1159/000533465 · Cited by 13
“However, there are no conclusive data in human studies to suggest the direct relationship between hyper-androgenism and hypertension in CAH [21, 77].”
Lašaitė, L., Navardauskaitė, R., Semeniene, K., & Verkauskienė, R. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01824-4 · Cited by 10
Health problems of adolescent and adult patients with 21-hydroxylase deficiency
Tajima, T. (2018) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.27.203 · Cited by 8
“(10) reported that in adults with 21OHD, obesity was observed in 42% of patients, hypercholesterolemia in 46%, and insulin resistance in 29%.”
BackgroundSandberg, D. E., Gardner, M., & Lapham, Z. K. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae668 · Cited by 7
Michelet, R., Bindellini, D., Melin, J., Neumann, U., Blankenstein, O., Huisinga, W., Johnson, T. N., Whitaker, M. J., Ross, R., & Kloft, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1090554 · Cited by 5
“Patients have an increased morbidity and mortality in adult life that may in part relate to suboptimal glucocorticoid therapy in their early years of life (Finkielstain et al., 2012; Han et al., 2014; Bancos et al., 2015; Bornstein et al., 2016).”
BackgroundSelf-citationClinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia
Erdeve, Ş. S., Aycan, Z., Çetinkaya, S. Ç., Öztürk, A. P., Baş, F., Poyrazoğlu, Ş., Darendelıler, F., Özsu, E., Şıklar, Z., Demiral, M., et al. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0216 · Cited by 8
Mittnacht, J., Choukair, D., Breil, T., Klose, D., Inta, I. M., & Bettendorf, M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14287 · Cited by 5
Hubska, J., Kępczyńska‐Nyk, A., Czady-Jurszewicz, K., & Ambroziak, U. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020653 · Cited by 8
“As the issue of short stature concerns the majority of people with CAH [40], it seems that an early diagnosis, a rapid referral to a medical facility with management expertise, conscientious monitoring with ongoing treatment adjustment, and the appropriate use of growth-enhancing strategies could help to improve the f…”
BackgroundAbalı, Z. Y., Yıldız, M., Abalı, S., Moniri, A., Baş, F., Önal, H., Çilsaat, G., Toksoy, G., Turan, S., Poyrazoğlu, Ş., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf612 · Cited by 5
TUHAN, H., Öztürk, T., Çatlı, G., Acar, S., Abacı, A., Egeli, T. Ü., Demir, K., Can, Ş., Güleryüz, H., Dündar, B. N., et al. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2001-57 · Cited by 3
Aldalaan, H., Alsagheir, A., Alghamdi, N. M., Alhuthil, R. T., Almslam, M. S., & Al‐Hamed, M. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1512161 · Cited by 2
Psychoendocrinology of congenital adrenal hyperplasia
Meyer‐Bahlburg, H. F. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00027-7 · Cited by 2
Linear growth in children and adolescents with congenital adrenal hyperplasia
Savage, M. O. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001361 · Cited by 3
Lawrence, N., Bacila, I. A., Tonge, J. J., Dawson, J., Collins, G. S., Lang, Z.-Q., Bryce, J., Alimussina, M., Chen, M., Ali, S., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf060 · Cited by 5
CaHASE: a Specialist Society Led Academic Collaboration to improve the management of CAH
Ross, R. J. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12485 · Cited by 2
Shifman, B. M., Dzeranova, L. K., Pigarova, E. A., Tiulpakov, A. N., & Fedorova, N. S. (2019) · Obesity and metabolism · doi:10.14341/omet10032 · Cited by 3
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_59 · Cited by 2
A Rationale for Mineralocorticoid Supplementation in Classic Congenital Adrenal Hyperplasia
Speiser, P. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375531 · Cited by 1
The Effect of Implementing Standard Recommendations For Congenital Adrenal Hyperplasia
Gillis, D. (2017) · Endocrine Practice · doi:10.4158/ep171834.co · Cited by 1
Diagnosis and Management of Congenital Adrenal Hyperplasia in Children and Adults
Prete, A., Feliciano, C., Mitchelhill, I., & Arlt, W. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_35 · Cited by 1
Kara, Z., Demir, A. N., Sulu, C., Durcan, E., Uysal, S., Turan, H., Özkaya, H. M., Evliyaoğlu, S. O., Ercan, O., & Gönen, M. S. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0060 · Cited by 1
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-1 · Cited by 1
Hauffa, B. P., Binder, G., Bonfig, W., Bettendorf, M., & Dörr, H. G. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-019-0697-1
Nosé, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52480-3.50077-9
López, J. A. G., & Catalán, M. I. G. (1998) · Revista de la Facultad de Derecho de la Universidad Complutense · Cited by 2
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Tseng, T., Koppin, C. M., & Geffner, M. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_59
Congenital Adrenal Hyperplasia in the Adolescent
Kim, M. S., Liang, M. C., Kokorowski, P. K., Tseng, T., Koppin, C. M., & Geffner, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-319-17002-2_59-2
Bachiller, B. R., Luque‐Ramírez, M., Rodríguez‐Jiménez, C., & Blanco, F. J. A. (2024) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2023.12.002
Innovative Pharmacometric Approaches to Inform Drug Development and Clinical Use
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4503-4
Bachiller, B. R., Luque‐Ramírez, M., Rodríguez‐Jiménez, C., & Blanco, F. J. A. (2024) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2024.05.003
Fekete, B., Bíró, K., Gyergyay, F., Polk, N., Horváth, O. N., Géczi, L., Patócs, A., & Budai, B. (2024) · Cancers · doi:10.3390/cancers16152760
McCracken, C., Kaabi, O., Crawford, M., Gardner, M. D., Getahun, D., Goodman, M. G., Khorashad, B. S., Lash, T. L., Roblin, D. W., Vupputuri, S. X., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.09.005
Hyperplasie congénitale des surrénales : formes précoces
Levaillant, L., Bouhours‐Nouet, N., Rouleau, S., Amsellem‐Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(25)85172-x
McElvaney, J., Ali, S., Frank, A., Longmuir, S., McNeilly, J., Alimussina, M., McGowan, R., & Ahmed, S. F. (2025) · Clinical Endocrinology · doi:10.1111/cen.70058
“The CaHASE cohort, for instance, identified that adult women with classic CAH were shorter and had higher BMI than those with the non ‐ classic form of the disease [22].”
Hiperplasia suprarrenal congénita: formas precoces
Levaillant, L., Bouhours-Nouet, N., Rouleau, S., Amsellem-Jager, J., Donzeau, A., Briet, C., & Coutant, R. (2025) · EMC - Pediatría · doi:10.1016/s1245-1789(25)51124-1
Metadata
- Authors
- Han, T. S., Conway, G. S., Willis, D. S., Krone, N., Rees, D. A., Stimson, R. H., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), T. U. K. C. A. H. A. S. E.
- Affiliations
- National Health Service (GB)
- University College Hospital (GB)
- Society for Endocrinology (GB)
- University of Birmingham (GB)
- Centre for Endocrine and Diabetes Sciences (D.A.R.), Institute for Molecular and Experimental Medicine, Cardiff University, Cardiff CF10 3US, United Kingdom
- The Queen's Medical Research Institute (GB)
- University of Sheffield (GB)
- Corresponding author
- Ross, R. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-08-01
- Volume
- 99
- Issue
- 8
- Pages
- E1547-E1555
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2102643461
- Cited by
- 65
- References
- 41
- Citations by year
- 2025: 7 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 5 · 2020: 2 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 3 · 2014: 1
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation (RG/11/4/28734)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, short stature, hypertension, mineralocorticoid therapy, glucocorticoid therapy, disease severity, genotypes, diagnosis timing, health outcomes, quality of life, insulin sensitivity, lipid profile, adiposity, developmental programming
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Body Height, Cardiovascular Diseases, Cross-Sectional Studies, Female, United Kingdom, Humans, Male, Middle Aged, Prognosis, Risk Factors, Severity of Illness Index, Cohort Studies, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.